Td Asset Management Inc Dice Therapeutics, Inc. Transaction History

Td Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$19.77 - $42.23 $69,452 - $148,353	3,513 Added 6.14%	60,739 $1.9 Million
Q1 2022 May 10, 2022	BUY	$14.54 - $25.02 $142,492 - $245,196	9,800 Added 20.66%	57,226 $1.1 Million
Q4 2021 Feb 10, 2022	BUY	$22.41 - $37.54 $147,906 - $247,764	6,600 Added 16.17%	47,426 $1.2 Million
Q3 2021 Nov 09, 2021	BUY	$31.92 - $37.0 $1.3 Million - $1.51 Million	40,826 New	40,826 $1.34 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.